HomeInsightsStock Comparison

Hindustan Bio Sciences Ltd vs Jubilant Pharmova Ltd Stock Comparison

Hindustan Bio Sciences Ltd vs Jubilant Pharmova Ltd Stock Comparison

Last Updated on: Apr 29, 2025

Key Highlights

  • The Latest Trading Price of Hindustan Bio Sciences Ltd is ₹ 7.89 as of 29 Apr 10:52.
  • The P/E Ratio of Hindustan Bio Sciences Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Jubilant Pharmova Ltd changed from 4.4 on March 2020 to 116.5 on March 2024 . This represents a CAGR of 92.56% over 5 years.
  • The Market Cap of Hindustan Bio Sciences Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Jubilant Pharmova Ltd changed from ₹ 3964 crore on March 2020 to ₹ 9056 crore on March 2024 . This represents a CAGR of 17.97% over 5 years.
  • The revenue of Hindustan Bio Sciences Ltd for the Dec '24 is ₹ 0 crore as compare to the Sep '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Jubilant Pharmova Ltd for the Dec '24 is ₹ 1830 crore as compare to the Sep '24 revenue of ₹ 1774 crore. This represent the growth of 3.21%.
  • The ebitda of Hindustan Bio Sciences Ltd for the Dec '24 is ₹ 0 crore as compare to the Sep '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Jubilant Pharmova Ltd for the Dec '24 is ₹ 277.4 crore as compare to the Sep '24 ebitda of ₹ 296.8 crore. This represent the decline of -6.54%.
  • The net profit of Hindustan Bio Sciences Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Jubilant Pharmova Ltd changed from ₹ 6 crore to ₹ 100.7 crore over 7 quarters. This represents a CAGR of 401.11% .
  • The Dividend Payout of Hindustan Bio Sciences Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Jubilant Pharmova Ltd changed from 24.8 % on March 2020 to 251.58 % on March 2024 . This represents a CAGR of 58.94% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Hindustan Bio Sciences Ltd

  • Hindustan Bio Science Ltd (Formerly known Hindustan Softel Ltd) was incorporated as Public Limited Company on December 16, 1991.
  • The Company engaged in the manufacturing and sale of pharmaceutical products is an integrated firm with diversified operations in pharmaceutical and biotechnology sectors.
  • The Company initially commenced operations in 1992 by sourcing bulk drugs (APIs) and drug intermediates for the Industry with a wellspring of global suppliers and associates. Previously, it was engaged in cement manufacturing and due to sluggish in the industry the company diversified its business into Bio Technology & Pharmaceuticals activities and the name of the Company was changed from Garuda Cements to Hindustan Bio-Sciences Ltd. In 2001, it diversified into software field and subsequently changed its name to Hindustan Softel Limited which presently got changed into Hindustan Bio Sciences Ltd.

About Jubilant Pharmova Ltd

  • Jubilant Pharmova Limited, (Formerly known as Jubilant Life Sciences Limited), is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.
  • The Company is engaged in pharmaceuticals, contract research and development services and proprietary novel drugs.
  • The pharmaceuticals segment, through wholly owned subsidiary Jubilant Pharma Limited, is engaged in manufacture and supply of Active Pharmaceutical Ingredients (APIs), Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Contract Manufacturing of Sterile Injectables and Non-Sterile Products through 6 US FDA approved manufacturing facilities in India, USA and Canada with a network of over 48 radiopharmacies in the USA. The contract research and development segment provides drug discovery and development services as well as clinical data software and service solutions.

Hindustan Bio Sciences Ltd News Hub

News

Hindustan Bio Sciences announces board meeting date

Hindustan Bio Sciences will hold a meeting of the Board of Directors of the Company on 23 ...

Read more

16 Apr 2025 10:41

News

Hindustan Bio Sciences to conduct board meeting

Hindustan Bio Sciences will hold a meeting of the Board of Directors of the Company on 30 ...

Read more

20 Jan 2025 17:29

News

Hindustan Bio Sciences to table results

Hindustan Bio Sciences will hold a meeting of the Board of Directors of the Company on 30 ...

Read more

17 Oct 2024 17:15

News

Hindustan Bio Sciences to hold AGM

Hindustan Bio Sciences announced that the 32nd Annual General Meeting (AGM) of the company...

Read more

02 Aug 2024 16:49

News

Hindustan Bio Sciences schedules AGM

Hindustan Bio Sciences announced that the 32th Annual General Meeting (AGM) of the company...

Read more

02 Aug 2024 16:42

News

Hindustan Bio Sciences announces board meeting date

Hindustan Bio Sciences will hold a meeting of the Board of Directors of the Company on 31 ...

Read more

23 Jul 2024 12:05

Jubilant Pharmova Ltd News Hub

News

Jubilant Pharmova arm gets EIR from USFDA for Maryland facility

The US Food and Drug Administration (USFDA) had classified the inspection as voluntary act...

Read more

13 Mar 2025 10:18

News

Volumes spurt at Jubilant Pharmova Ltd counter

K E C International Ltd, Indian Bank, J B Chemicals & Pharmaceuticals Ltd, Birla Corporati...

Read more

13 Mar 2025 11:00

News

Jubilant Pharmova announces acquisition of 80% stake in JASMIN

Jubilant Biosys Innovative Research Services, Singapore (JBIRSPL), a subsidiary of Jubilan...

Read more

29 Jan 2025 09:03

News

Jubilant Pharmova to discuss results

Jubilant Pharmova will hold a meeting of the Board of Directors of the Company on 31 Janua...

Read more

23 Jan 2025 14:48

News

Jubilant Cadista's Salisbury unit undergoes USFDA inspection

Jubilant Pharmova announced that its subsidiary Jubilant Cadista Pharmaceuticals Inc., (Ju...

Read more

17 Jan 2025 09:14

News

Jubilant Pharmova's Salisbury-based facility gets five observations from US FDA

In an exchange filing made today, the company informed that the United States Food and Dru...

Read more

17 Jan 2025 09:34

SWOT Analysis Of Jubilant Pharmova Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Hindustan Bio Sciences Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Jubilant Pharmova Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Hindustan Bio Sciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Hindustan Bio Sciences Ltd and Jubilant Pharmova Ltd

Which company has a larger market capitalization, Hindustan Bio Sciences Ltd or Jubilant Pharmova Ltd?

Market cap of Hindustan Bio Sciences Ltd is 8 Cr while Market cap of Jubilant Pharmova Ltd is 14,458 Cr

What are the key factors driving the stock performance of Hindustan Bio Sciences Ltd and Jubilant Pharmova Ltd?

The stock performance of Hindustan Bio Sciences Ltd and Jubilant Pharmova Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Hindustan Bio Sciences Ltd and Jubilant Pharmova Ltd?

As of April 29, 2025, the Hindustan Bio Sciences Ltd stock price is INR ₹7.89. On the other hand, Jubilant Pharmova Ltd stock price is INR ₹907.6.

How do dividend payouts of Hindustan Bio Sciences Ltd and Jubilant Pharmova Ltd compare?

To compare the dividend payouts of Hindustan Bio Sciences Ltd and Jubilant Pharmova Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions